Kineta, Inc./De

Ownership Transactions Reported by 21 Insiders

Symbol
KA on Nasdaq
Industry
Pharmaceutical Preparations
Location
7683 Se 27 Th Street, Suite 481, Mercer Island, Washington

Insiders trading volume in the past year

Kineta, Inc./De executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Shawn Iadonato Director $3.08 M +$42.4 K +1.4% Apr 14, 2024
Raymond Bartoszek Director $978 K +$21 K +2.19% May 1, 2024
Marion R. Foote Director $644 K Oct 11, 2023
Craig W. Philips President and Secretary $430 K +$18.3 K +4.45% Apr 14, 2024
Richard Peters Director $396 K Apr 12, 2023
Paulash Mohsen Chief Business Officer $266 K Feb 3, 2022
Ajay Verma EVP, Head of R&D $136 K Dec 1, 2021
Thierry Guillaudeux Chief Scientific Officer $97.6 K +$20 K +25.8% Apr 14, 2024
Pauline Kenny General Counsel & Secretary $83 K +$3.87 K +4.89% Sep 20, 2023
Keith Baker Chief Financial Officer $76 K +$10.7 K +16.3% Apr 14, 2024
Michael D. Wyzga Sr. VP & Chief Financial Officer $63 K Dec 2, 2022
Devin W. Smith SVP and General Counsel $62.8 K Dec 2, 2022
Marie Epstein Principal Accounting Officer $40 K Dec 2, 2022
Scott J. Dylla Director $18 K Jul 1, 2023
David Arkowitz Director Apr 12, 2023
Kimberlee C. Drapkin Director Jul 1, 2023
Richard A. Heyman Director Jun 2, 2021
Patricia L. Allen Director Jun 2, 2021
Cecil B. Pickett Director Jun 2, 2021
Lynne Zydowsky Director Jun 2, 2021
Jeffery W. Kelly Director Jun 2, 2021

Recent Insider Transactions by Companies or Individuals for Kineta, Inc./De

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership